Donald L. van der Peet

Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial

Surya S. A. Y. Biere, Mark I. van Berge Henegouwen, K. W. Maas et al. · The Lancet · 2012 · 1.7K citations

Surgical Oncology, Esophagus, Esophageal Cancer +9

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

Minimally Invasive Versus Open Esophageal Resection

Jennifer Straatman, Nicole van der Wielen, Miguel A. Cuesta et al. · Annals of Surgery · 2017 · 537 citations

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 334 citations

Terminal Ileitis, Gastroenterology, Multicentre Trial +4

Laparoscopic Sigmoid Resection for Diverticulitis Decreases Major Morbidity Rates: A Randomized Control Trial

Bastiaan Klarenbeek, Alexander A. F. A. Veenhof, Roberto Bergamaschi et al. · Annals of Surgery · 2008 · 326 citations